The care of patients with type 2 diabetes and chronic kidney disease requires a multidisciplinary approach; hence, this activity takes a multidisciplinary approach to educate clinicians of various disciplines. Nephrologist and clinical trialist George Bakris, MD, reviews the burden of diabetic kidney disease (DKD) and provides guideline recommendations to properly screen and prevent cardiovascular disease events in patients with DKD. Fellow clinical trialist and diabetes expert John Buse, MD, PhD, discusses the pharmacology and prescribing considerations of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and highlights this class while reviewing new consensus reports. Dr. Buse teams up with Dr. Bakris to discuss the cardiorenal benefits of GLP-1 RAs evidenced by cardiovascular outcomes trials and recent meta-analyses. Primary care and internal medicine specialist John Anderson, MD, joins Drs. Bakris and Buse to lead the discussion of 2 cases of patients with DKD. Dr. Anderson concludes by discussing the importance of multidisciplinary management in optimizing care for our patients with type 2 diabetes and chronic kidney disease.

This program is also available as a podcast. You may download it here:https://anchor.fm/t2d-ckd

Presenting Faculty

• 

  John E. Anderson, MD

  Internal Medicine and Diabetes
  The Frist Clinic
  Nashville, Tennessee

• 

  George Bakris, MD

  Professor of Medicine
  Director, American Heart Association Comprehensive Hypertension Center
  University of Chicago Medicine
  Chicago, Illinois

• 

  John B. Buse, MD, PhD

  Verne S. Caviness Distinguished Professor
  Director, Diabetes Center
  Director, NC Translational and Clinical Sciences Institute
  Senior Associate Dean, Clinical Research
  University of North Carolina School of Medicine
  Chapel Hill, North Carolina